Clinical Trial Update: Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study comparing nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN